City of Seattle v. Purdue Pharma L.P. et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:18-op-45089 |
| Nature of Suit | 360 Torts - Personal Injury - Other Personal Injury |
| Cause | 28:1332nr |
| Case Filed: | Jan 23, 2018 |
| Case in other court: | Washington Western, 2:17-cv-01577 |
| Last checked: Friday Nov 08, 2019 5:05 PM EST |
|
Defendant
Johnson & Johnson
|
Represented By
|
|
Defendant
Watson Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
Represented By
|
|
Defendant
Teva Pharmaceutical Industries Ltd.
|
Represented By
|
|
Defendant
Seattle Pain Center Medical Corporation
|
Represented By
|
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
|
Defendant
Purdue Pharma Inc.
|
Represented By
|
|
Defendant
Purdue Frederick Company, Inc.
|
Represented By
|
|
Defendant
Ortho-Mcneil-Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Frank D. Li
|
Represented By
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Janssen Pharmaceutica Inc.
|
Represented By
|
|
Defendant
Endo Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Endo Health Solutions Inc.
|
Represented By
|
|
Defendant
Does
|
|
|
Defendant
Cephalon Inc.
|
Represented By
|
|
Defendant
Allergan PLC
|
Represented By
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Plaintiff
City of Seattle
|
Represented By
|
| Docket last updated: 04/08/2019 8:53 PM EDT |
| Tuesday, October 24, 2017 | ||
| 1 | 1
NOTICE OF REMOVAL from King County Superior Court, case number 17 2-25504 1; , filed by Endo Pharmaceuticals, Inc., Endo Health Solutions, Inc..(Hineline, Curt) [Transferred from wawd on 1/23/2018.]
|
|
|
Att: 1
Civil Cover Sheet,
|
||
|
Att: 2
104 pgs
Complaint,
|
||
|
Att: 3
Exhibit Part 1,
|
||
|
Att: 4
Exhibit Part 2
|
||
| 2 | 2
CORPORATE DISCLOSURE STATEMENT identifying Corporate Parent Endo International plc for Endo Health Solutions, Inc., Endo Pharmaceuticals, Inc.. Filed pursuant to Fed.R.Civ.P 7.1. Filed by Endo Health Solutions, Inc., Endo Pharmaceuticals, Inc. (Hineline, Curt) [Transferred from wawd on 1/23/2018.]
|
|
| Wednesday, October 25, 2017 | ||
| 3 | 3
CORPORATE DISCLOSURE STATEMENT identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc.. Filed pursuant to Fed.R.Civ.P 7.1. Filed by Janssen Pharmaceuticals, Inc., Johnson & Johnson (Calfo, Angelo) [Transferred from wawd on 1/23/2018.]
|
|
| 4 | 4
CORPORATE DISCLOSURE STATEMENT identifying Corporate Parent Pharmaceutical Research Associates, Inc. for The Purdue Frederick Company, Inc.. Filed pursuant to Fed.R.Civ.P 7.1. Filed by Purdue Pharma L.P., Purdue Pharma, Inc., The Purdue Frederick Company, Inc. (Adams, Thomas) [Transferred from wawd on 1/23/2018.]
|
|
| Thursday, October 26, 2017 | ||
| NOTICE TO FILER: ATTORNEY NOT ADMITTED TO PRACTICE: Counsel, Emilee Sisco is not admitted to practice in the U.S. District Court, Western District of Washington. Counsel must file an Attorney Admission Petition form and register for ECF. These forms can be found under the Attorneys tab/Attorney Admissions on our courts website - wawd.uscourts.gov.If you have any questions about e-filing, registration or training, please call the ECF Support Desk at 1-866-232-9293. (RE) [Transferred from wawd on 1/23/2018.] | ||
| Judge Thomas S. Zilly added. (RE) [Transferred from wawd on 1/23/2018.] | ||
| 5 | 5
LETTER from Clerk to counsel re receipt of case from King County Superior Court and advising of WAWD case number and judge assignment. (RE) [Transferred from wawd on 1/23/2018.]
|
|
| Friday, October 27, 2017 | ||
| 6 | 6
Agreed MOTION for Extension of Time to File Answer or File Dispositive Motions , filed by Defendants Purdue Pharma Inc, Purdue Pharma L.P., The Purdue Frederick Company Inc. Noting Date 10/27/2017, (Adams, Thomas) [Transferred from wawd on 1/23/2018.]
|
|
|
Att: 1
Proposed Order
|
||
| Monday, October 30, 2017 | ||
| NOTICE TO FILER: JURY DEMAND: The Clerk has removed plaintiff's jury demand flag entered by defendant's counsel upon case opening. Plaintiff(s) counsel must now file a separate Jury Demand in order to advise the court of this request. Thank you. (RE) [Transferred from wawd on 1/23/2018.] | ||
| 7 | 7
NOTICE of Appearance by attorney Carolyn Robbs Bilanko on behalf of Defendants Endo Health Solutions Inc, Endo Pharmaceuticals, Inc.. (Bilanko, Carolyn) [Transferred from wawd on 1/23/2018.]
|
|
| Tuesday, October 31, 2017 | ||
| 8 | 8
MINUTE ORDER granting6 Agreed Motion for Extension of Time to Answer or File Dispositive Motions; Any responsive pleading or motion shall be filed ninety (90) days of the date of this Minute Order, authorized by Judge Thomas S. Zilly. (SWT) [Transferred from wawd on 1/23/2018.]
|
|
| Wednesday, November 01, 2017 | ||
| Attorney Bruce A Rubin for Actavis LLC, Allergan PLC, Watson Pharmaceuticals Inc added; per9 Notice of Appearance. (SWT) [Transferred from wawd on 1/23/2018.] | ||
| 9 | 9
NOTICE of Appearance by attorney Kent Michael Fandel on behalf of Defendants Actavis LLC, Allergan PLC, Watson Pharmaceuticals Inc. (Fandel, Kent) [Transferred from wawd on 1/23/2018.]
|
|
| 10 | 10
CORPORATE DISCLOSURE STATEMENT identifying Corporate Parent Allergan PLC, Other Affiliate Allergan Finance LLC for Allergan PLC. Filed pursuant to Fed.R.Civ.P 7.1. Filed by Allergan PLC (Fandel, Kent) [Transferred from wawd on 1/23/2018.]
|
|
| Thursday, November 02, 2017 | ||
| 11 | 11
MOTION to Remand and for Expedited Consideration , filed by Plaintiff City of Seattle. Noting Date 11/24/2017, (Berman, Steve) [Transferred from wawd on 1/23/2018.]
|
|
|
Att: 1
Proposed Order
|
||
| 12 | 12
DECLARATION of Steve W. Berman filed by Plaintiff City of Seattle re11 MOTION to Remand and for Expedited Consideration(Berman, Steve) [Transferred from wawd on 1/23/2018.]
|
|
|
Att: 1
Exhibit A,
|
||
|
Att: 2
Exhibit B,
|
||
|
Att: 3
Exhibit C,
|
||
|
Att: 4
Exhibit D,
|
||
|
Att: 5
Exhibit E,
|
||
|
Att: 6
Exhibit F,
|
||
|
Att: 7
Exhibit G,
|
||
|
Att: 8
Exhibit H,
|
||
|
Att: 9
Exhibit I,
|
||
|
Att: 10
Exhibit J
|
||
| Thursday, November 09, 2017 | ||
| 13 | 13
APPLICATION OF ATTORNEY Donna Marie Welch FOR LEAVE TO APPEAR PRO HAC VICE for Defendants Actavis LLC, Allergan PLC, Watson Pharmaceuticals Inc (Fee Paid) Receipt No. 0981-5085776 (Fandel, Kent) [Transferred from wawd on 1/23/2018.]
|
|
| 14 | 14
APPLICATION OF ATTORNEY Jennifer Gardner Levy FOR LEAVE TO APPEAR PRO HAC VICE for Defendants Actavis LLC, Allergan PLC, Watson Pharmaceuticals Inc (Fee Paid) Receipt No. 0981-5085795 (Fandel, Kent) [Transferred from wawd on 1/23/2018.]
|
|
| 15 | 15
APPLICATION OF ATTORNEY Martin Lewis Roth FOR LEAVE TO APPEAR PRO HAC VICE for Defendants Actavis LLC, Allergan PLC, Watson Pharmaceuticals Inc (Fee Paid) Receipt No. 0981-5085802 (Fandel, Kent) [Transferred from wawd on 1/23/2018.]
|
|
| 16 | 16
APPLICATION OF ATTORNEY Timothy William Knapp FOR LEAVE TO APPEAR PRO HAC VICE for Defendants Actavis LLC, Allergan PLC, Watson Pharmaceuticals Inc (Fee Paid) Receipt No. 0981-5085811 (Fandel, Kent) [Transferred from wawd on 1/23/2018.]
|
|
| 17 | 17
DEMAND for JURY TRIAL by Plaintiff City of Seattle (Berman, Steve) [Transferred from wawd on 1/23/2018.]
|
|
| 18 | 18 ORDER re13 Application for Leave to Appear Pro Hac Vice. The Court ADMITS Attorney Donna M Welch for Actavis LLC, Allergan PLC and Watson Pharmaceuticals Inc, by Clerk William M McCool. No document associated with this docket entry, text only. NOTE TO COUNSEL: Local counsel agrees to sign all filings and to be prepared to handle the matter, including the trial thereof, in the event the applicant is unable to be present on any date scheduled by the court, pursuant to LCR 83.1(d). (CDA) [Transferred from wawd on 1/23/2018.] | |
| 19 | 19 ORDER re14 Application for Leave to Appear Pro Hac Vice. The Court ADMITS Attorney Jennifer G Levy for Actavis LLC, Allergan PLC, and Watson Pharmaceuticals Inc, by Clerk William M McCool. No document associated with this docket entry, text only. NOTE TO COUNSEL: Local counsel agrees to sign all filings and to be prepared to handle the matter, including the trial thereof, in the event the applicant is unable to be present on any date scheduled by the court, pursuant to LCR 83.1(d). (CDA) [Transferred from wawd on 1/23/2018.] | |
| 20 | 20 ORDER re15 Application for Leave to Appear Pro Hac Vice. The Court ADMITS Attorney Martin L Roth for Actavis LLC, Allergan PLC, and Watson Pharmaceuticals Inc, by Clerk William M McCool. No document associated with this docket entry, text only. NOTE TO COUNSEL: Local counsel agrees to sign all filings and to be prepared to handle the matter, including the trial thereof, in the event the applicant is unable to be present on any date scheduled by the court, pursuant to LCR 83.1(d). (CDA) [Transferred from wawd on 1/23/2018.] | |
| 21 | 21 ORDER re16 Application for Leave to Appear Pro Hac Vice. The Court ADMITS Attorney Timothy W Knapp for Actavis LLC, Allergan PLC,and for Watson Pharmaceuticals Inc, by Clerk William M McCool. No document associated with this docket entry, text only. NOTE TO COUNSEL: Local counsel agrees to sign all filings and to be prepared to handle the matter, including the trial thereof, in the event the applicant is unable to be present on any date scheduled by the court, pursuant to LCR 83.1(d). (CDA) [Transferred from wawd on 1/23/2018.] | |
| 22 | 22
MOTION to Stay and for Relief From Deadlines , filed by Defendants Purdue Pharma Inc, Purdue Pharma L.P., The Purdue Frederick Company Inc. Noting Date 11/17/2017, (Adams, Thomas) [Transferred from wawd on 1/23/2018.]
|
|
|
Att: 1
Proposed Order
|
||
| Wednesday, November 15, 2017 | ||
| 23 | 23
RESPONSE, by Plaintiff City of Seattle, to22 MOTION to Stay and for Relief From Deadlines . (Berman, Steve) [Transferred from wawd on 1/23/2018.]
|
|
| 24 | 24
DECLARATION of Ben M. Harrington filed by Plaintiff City of Seattle re22 MOTION to Stay and for Relief From Deadlines(Berman, Steve) [Transferred from wawd on 1/23/2018.]
|
|
|
Att: 1
Exhibit 1,
|
||
|
Att: 2
Exhibit 2
|
||
| Friday, November 17, 2017 | ||
| 25 | 25
REPLY, filed by Defendants Purdue Pharma Inc, Purdue Pharma L.P., The Purdue Frederick Company Inc, TO RESPONSE to22 MOTION to Stay and for Relief From Deadlines (Adams, Thomas) [Transferred from wawd on 1/23/2018.]
|
|
| Monday, November 20, 2017 | ||
| 26 | 26
RESPONSE, by Defendants Endo Health Solutions Inc, Endo Pharmaceuticals, Inc., to11 MOTION to Remand and for Expedited Consideration .(Hineline, Curt) [Transferred from wawd on 1/23/2018.]
|
|
|
Att: 1
Exhibit 1,
|
||
|
Att: 2
Exhibit 2,
|
||
|
Att: 3
Exhibit 3
|
||
| Friday, November 24, 2017 | ||
| 27 | 27
REPLY, filed by Plaintiff City of Seattle, TO RESPONSE to11 MOTION to Remand and for Expedited Consideration (Berman, Steve) [Transferred from wawd on 1/23/2018.]
|
|
| 28 | 28
DECLARATION of Jennifer Fountain Connolly filed by Plaintiff City of Seattle re11 MOTION to Remand and for Expedited Consideration(Berman, Steve) [Transferred from wawd on 1/23/2018.]
|
|
|
Att: 1
Exhibit 1,
|
||
|
Att: 2
Exhibit 2,
|
||
|
Att: 3
Exhibit 3,
|
||
|
Att: 4
Exhibit 4
|
||
| 29 | 29
REPLY, filed by Plaintiff City of Seattle, TO RESPONSE to11 MOTION to Remand and for Expedited Consideration (Berman, Steve) [Transferred from wawd on 1/23/2018.]
|
|
| Wednesday, November 29, 2017 | ||
| 30 | 30
NOTICE of Supplemental Authority re11 MOTION to Remand and for Expedited Consideration by Plaintiff City of Seattle(Berman, Steve) [Transferred from wawd on 1/23/2018.]
|
|
|
Att: 1
Exhibit A
|
||
| Tuesday, December 05, 2017 | ||
| Attorney James Harlan Wendell for Actavis LLC, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals USA Inc, Watson Laboratories Inc added; per31 Notice of Appearance. (SWT) [Transferred from wawd on 1/23/2018.] | ||
| 31 | 31
NOTICE of Appearance by attorney Brendan Thomas Mangan on behalf of Defendants Actavis LLC, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals USA Inc, Watson Laboratories Inc. (Mangan, Brendan) [Transferred from wawd on 1/23/2018.]
|
|
| 32 | 32
CORPORATE DISCLOSURE STATEMENT identifying Corporate Parent Teva Pharmaceutical Industries Ltd., Corporate Parent Cupric Holding Co., Inc. for Cephalon Inc; Corporate Parent Teva Pharmaceutical Industries Ltd for Actavis LLC, Actavis Pharma Inc; Corporate Parent Orvet UK, Corporate Parent Teva Pharmaceutical Holdings Cooperative U.A., Corporate Parent Teva Pharmaceuticals Europe B.V., Corporate Parent Teva Pharmaceutical Industries Ltd., Corporate Parent IVAX LLC for Teva Pharmaceuticals USA Inc; Corporate Parent Teva Pharmaceutical Industries, Ltd. for Watson Laboratories Inc. Filed pursuant to Fed.R.Civ.P 7.1. Filed by Actavis LLC, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals USA Inc, Watson Laboratories Inc (Mangan, Brendan)[Transferred from wawd on 1/23/2018.]
|
|
| Wednesday, December 06, 2017 | ||
| 33 | 33
NOTICE of Developments in In Re: National Prescription Opiate Litigation ; filed by Plaintiff City of Seattle.(Berman, Steve) [Transferred from wawd on 1/23/2018.]
|
|
|
Att: 1
Exhibit A
|
||
| Tuesday, December 19, 2017 | ||
| 34 | 34
MINUTE ORDER granting in part and denying in part Defendants'22 Motion to Stay and for Relief From Deadlines . The deadline for any responsive pleading or motion is EXTENDED from January 29, 2018, to March 16, 2018. Plaintiff's motion to remand, docket no.11 , is RENOTED to February 2, 2018, and will be decided, if appropriate, after the United States Judicial Panel on Multidistrict Litigation ("MDL") issues a ruling on plaintiff's opposition to the conditional transfer order in MDL No. 2804, which is currently set for hearing without oral argument on January 25, 2018. The request for a stay is DENIED. Authorized by Judge Thomas S. Zilly. (TH) [Transferred from wawd on 1/23/2018.]
|
|
| Tuesday, December 26, 2017 | ||
| Case sent to District of Northern District of Ohio by electronic case transfer. (SWT) [Transferred from wawd on 1/23/2018.] | ||
| 35 | 35
ORDER Lifting Stay of Conditional Transfer Order (MDL 2804 CONDITIONAL TRANSFER ORDER (CTO 1)); in re National Prescription Opiate Litigation; Northern District of Ohio; assigned to Judge Dan A. Polster. (SWT) [Transferred from wawd on 1/23/2018.]
|
|
| Tuesday, January 23, 2018 | ||
| 36 | 36
CASE TRANSFERRED IN from District of Washington Western. Case number 2:17-cv-01577. Original file, certified copy of transfer order and docket sheet received.
|
|